99mTc-labeled nanocolloid drugs: development methods

99mTc-labeled nanocolloid drugs: development methods

Bibliographic Details
Parent link:Scientific Reports
Vol. 10, iss. 1.— 2020.— [14013, 9 p.]
Corporate Author: Национальный исследовательский Томский политехнический университет Физико-технический институт Лаборатория радиационного контроля № 31
Other Authors: Sadkin V. L. Vladimir Leonidovich, Skuridin V. S. Viktor Sergeyevich, Nesterov E. A. Evgeny Alexandrovich, Stasyuk (Stasiuk) E. S. Elena Sergeyevna, Rogov A. S. Alexander Sergeyevich, Varlamova N. V. Natalya Valeryevna, Zelchan R. V. Roman Vladimirovich
Summary:Title screen
The work considers the problem of obtaining nanocolloid radiopharmaceuticals (RPs) and studying their functional suitability for diagnosing sentinel lymph nodes (SLN) in cancer patients. Two principal approaches to the formation of technetium-99m-labeled particles based on inorganic and organic matrices were considered when carrying out research to develop methods for the production of nanocolloid RPs. The composition of the reagents and the conditions for obtaining nanocolloid radiopharmaceuticals were determined. The functional suitability of new RPs for scintigraphic diagnostics of sentinel lymph nodes has been studied.
Published: 2020
Subjects:
электронный ресурс
труды учёных ТПУ
cancer imaging
nanoparticle synthesis
drug development
рак
лекарства
Online Access:https://doi.org/10.1038/s41598-020-70991-2
Format: Electronic Book Chapter
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=663262

Similar Items

Similar Items